Table 2.
Time to first treatment and hazard ratio according to IGVH status, TERT levels, and TP53 levels showing their effects on disease progression in chronic lymphocytic leukemia with 13q14 deletion.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.